Global Information
회사소개 | 문의 | 비교리스트

세계의 모르핀 시장(2020-2026년)

Morphine Market 2020-2026

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949611
페이지 정보 영문
가격
US $ 3,600 ₩ 4,243,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,658,000 Printable PDF (Enterprise License)


세계의 모르핀 시장(2020-2026년) Morphine Market 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

세계의 모르핀 시장은 예측기간 중 크게 성장할 것으로 추정됩니다. 시장 성장을 촉진하는 주요 요인에는 장기적인 통증 관리를 위한 서방성 모르핀약 수요 증가가 포함됩니다. 또한 라이프스타일 변화와 외과 수술중 수요 증가도 시장 성장에 기여하고 있습니다. 시장에는 다양한 약이 있습니다. Dsuvia는 새로운 제품의 하나로, 이것은 병원에서의 외과 수술에서 긴급한 경우에 처방되는 의료 전문가가 제한된 규제에서 사용하는 모르핀약의 하나입니다. Dsuvia는 환자가 약을 삼킬 수 없는 경우에만 처방됩니다.

세계의 모르핀 시장은 종류와 용도에 기반해 세분화됩니다. 종류별로는 캡슐, 경구 정제, 주사로 분류됩니다. 용도별로는 기침 억제제, 설사 억제제, 마취, 기타로 분류됩니다. 지역별로는 북미 , 유럽, 아시아태평양 및 기타 국가로 분류되고 있습니다. 의료 혁신을 위한 조사 개발에서의 모르핀 대량 소비에 의해 북미가 세계의 모르핀 시장에서 지배적인 위치를 차지하고 있습니다.

모르핀을 제공하고 있는 주요 기업에는 Allergan PLC, Purdue Pharma LP, Mallinckrodt PLC, Mylan NV, Sun Pharmaceutical Industries, Ltd., Macfarian Smith Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd. 등이 있습니다. 이러한 기업은 시장에서의 경쟁력을 유지하기 위해 다양한 전략을 채용하고 있습니다. 예를 들어 2018년 7월 Sun Pharmaceuticals Industries Ltd.는 장기 오피오이드 치료의 격렬한 통증을 경감하기 위해 황산 모르핀을 도입했습니다.

세계의 모르핀 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 저해요인 분석, 종류·용도·지역별 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요, 시장 기회 등 체계적인 정보를 제공합니다.

목차

제1장 보고서 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트의 인사이트와 현재 시장 동향
  • 규칙과 규제

제3장 경쟁 상황

  • 기업 점유율 분석
  • 주요 전략 분석
  • 주요 기업 분석
    • Allergan PLC
    • Purdue Pharma LP
    • Mallinckrodt PLC
    • Mylan N.V.
    • Sun Pharmaceutical Industries, Ltd.

제4장 시장 결정요인

  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회

제5장 시장 세분화

  • 종류별
    • 주입
    • 캡슐
    • 경구 정제
  • 용도별
    • 기침 억제제
    • 설사 억제제
    • 마취

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양
  • 기타 지역

제7장 기업 개요

  • Allergan PLC
  • Alcaliber S.A.
  • Daiichi Sankyo, Inc.
  • Macfarian Smith, Ltd.(A Part of Johnson Matthey PLC's Fine Chemicals Division)
  • Mallinckrodt PLC
  • Manus Aktteva Biopharma LLP
  • Mylan N.V.
  • Mayne Pharma Group, Ltd.
  • Pfizer, Inc.
  • Purdue Pharma LP
  • Sanofi S.A.
  • Sun Pharmaceuticals Industries, Ltd.
  • Taj Pharmaceuticals, Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries, Ltd.
KSM 20.08.07

LIST OF TABLES

  • 1. GLOBAL MORPHINE MARKET RESEARCH AND ANALYSIS BY TYPE,2019-2026 ($ MILLION)
  • 2. GLOBAL MORPHINEINJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL MORPHINECAPSULE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL MORPHINE ORAL TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL MORPHINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 6. GLOBAL COUGH SUPPREESANT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL DIARRHEA SUPPRESSANT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL ANESTHESIAMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL MORPHINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 10. NORTH AMERICAN MORPHINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 11. NORTH AMERICAN MORPHINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 12. NORTH AMERICAN MORPHINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 13. EUROPEAN MORPHINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 14. EUROPEAN MORPHINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 15. EUROPEAN MORPHINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 16. ASIA-PACIFIC MORPHINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 17. ASIA-PACIFIC MORPHINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 18. ASIA-PACIFIC MORPHINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 19. REST OF THE WORLD MORPHINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 20. REST OF THE WORLD MORPHINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MORPHINE MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL MORPHINE MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
  • 3. GLOBAL MORPHINE MARKETSHARE BY GEOGRAPHY, 2019VS 2026 (%)
  • 4. US MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD MORPHINE MARKET SIZE, 2019-2026 ($ MILLION)

Global Morphine Market Size, Share & Trends Analysis Report, by Type (Capsules, Oral Tablets, and Injection), by Application (Cough Suppressant, Diarrhea Suppressant, and Anesthesia) and Forecast Period, 2020-2026

The global morphine market is estimated to grow significantly during the forecast period. The major factors encouraging market growth include the rising demand for extended-release morphine drugs for long term pain management. Moreover, change in lifestyle and increases the demand during surgical procedures is also contributing to the market growth. There are various drugs available in the market. One of the novel products is Dsuvia, one of the morphine drugs used by medical professionals under restricted regulations that are prescribed for emergency cases, in surgical operations by hospitals. Dsuvia dosage only prescribed when the patient is incapable to swallow the medicine.

The global morphinemarket is segmented based on type and application. Based on type, the market is classified into capsules, oral tablets and injection. Based on the application, the market is classified intocough suppressants, diarrhea suppressants, anesthesia, and others.Geographically, the global Morphine market is classified into North America, Europe, Asia-Pacific and Rest of world. North America dominates the global morphine market due to high consumption of morphine in research & development for medical innovation.

The major companies providing morphine include Allergan PLC, Purdue Pharma LP, Mallinckrodt PLC, Mylan N.V., Sun Pharmaceutical Industries, Ltd., Macfarian Smith, Ltd., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries, Ltd.are among others.These players are adopting various strategies in order to stay competitive in the market. For instance, in July 2018, Sun Pharmaceuticals Industries Ltd. Introduced Morphine sulfate extended to reduce the severe pain for long-term opioid treatments.

Research Methodology

The market study of the global morphine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity toour reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis ofmarket size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global MorphineMarket Research and Analysisby Type
  • Global MorphineMarket Research and Analysisby Application

The Report Covers:

  • Comprehensive research methodologies of the global morphine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global morphinemarket.
  • Insights about market determinants which are stimulating the global morphine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Allergan PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Purdue Pharma LP
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Mallinckrodt PLC
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Mylan N.V.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Sun Pharmaceutical Industries, Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Morphine Market by Type
    • 5.1.1. Injection
    • 5.1.2. Capsule
    • 5.1.3. Oral Tablets
  • 5.2. Global Morphine Market by Application
    • 5.2.1. Cough Suppressant
    • 5.2.2. Diarrhea Suppressant
    • 5.2.3. Anesthesia

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Allergan PLC
  • 7.2. Alcaliber S.A.
  • 7.3. Daiichi Sankyo, Inc.
  • 7.4. Macfarian Smith, Ltd. (A Part of Johnson Matthey PLC's Fine Chemicals Division)
  • 7.5. Mallinckrodt PLC
  • 7.6. Manus Aktteva Biopharma LLP
  • 7.7. Mylan N.V.
  • 7.8. Mayne Pharma Group, Ltd.
  • 7.9. Pfizer, Inc.
  • 7.10. Purdue Pharma LP
  • 7.11. Sanofi S.A.
  • 7.12. Sun Pharmaceuticals Industries, Ltd.
  • 7.13. Taj Pharmaceuticals, Ltd.
  • 7.14. Takeda Pharmaceutical Co. Ltd.
  • 7.15. Teva Pharmaceutical Industries, Ltd.
Back to Top
전화 문의
F A Q